Health Care & Life Sciences » Pharmaceuticals | United Laboratories International Holdings Ltd.

United Laboratories International Holdings Ltd. | Ownership

Companies that own United Laboratories International Holdings Ltd.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Credit Suisse AG
29,527,020
1.8%
17,671,533
0.07%
07/31/2018
Norges Bank Investment Management
21,427,133
1.31%
4,635,691
0%
12/31/2017
Dimensional Fund Advisors LP
19,325,500
1.18%
-894,000
0%
04/30/2018
The Vanguard Group, Inc.
10,736,248
0.66%
50,000
0%
07/31/2018
BlackRock Fund Advisors
6,167,810
0.38%
0
0%
09/06/2018
BlackRock Advisors (UK) Ltd.
4,153,813
0.25%
0
0%
09/06/2018
Oberweis Asset Management, Inc.
3,214,000
0.2%
242,000
0.12%
03/31/2018
Lazard Asset Management LLC
3,033,226
0.19%
2,246,000
0%
05/31/2018
Standard Life Investments Ltd.
2,808,555
0.17%
0
0%
08/31/2018
Baring Asset Management (Asia) Ltd.
2,028,000
0.12%
2,028,000
0.06%
10/31/2017

About United Laboratories International Holdings

View Profile
Address
6 Fuk Wang Street
Hong Kong
Hong Kong
Employees -
Website http://www.tul.com.cn
Updated 07/08/2019
United Laboratories International Holdings Ltd. operates as an investment company, which engages in the manufacturing and sale of medicines, and the bulk and intermediate products used to produce finished goods. It operates through the following segments: Intermediate Products, Bulk Medicine, and Finished Products. The Intermediate Products segment offers two major products, such as T-Octylammonium Clavulanate and 6-APA.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.